The mission of the Alliance for Clinical Trials in Oncology (Alliance) and the American College of Surgeons Clinical Research Program (ACS CRP) is to reduce the impact of cancer through increased knowledge and awareness of new evidence and practice standards, greater participation of community oncology surgeons in cancer research and cancer care activities, development and implementation of evidence-based practices in surgical oncology, and expanded opportunities for meaningful health services research. The ACS CRP comprises four committees: Cancer Care Delivery Research, Cancer Care Standards Development, Dissemination & Implementation, and Education.
Sponsoring Panel Sessions at the annual ACS Clinical Congress is one way the ACS CRP helps Fellows stay ahead of the curve on the treatment of patients with cancer. Clinical Congress 2017, October 22−26 in San Diego, CA, will feature five Panel Sessions on an array of topics in oncology with a focus on increasing surgeon knowledge and elevating the care of oncology patients nationally.
CRP sessions at Clinical Congress
Management of the axilla in breast cancer
Laurie Kirstein, MD, FACS, surgical oncologist, Memorial Sloan Kettering Cancer Center, New York, NY, and Judy Boughey, MD, FACS, Chair, ACS CRP Education Committee, and co-author of this article, will moderate Management of the Axilla in Breast Cancer, 11:30 am–1:00 pm, Monday, October 23. This session, co-sponsored by the Commission on Cancer (CoC), will focus on management of the axilla both in patients treated with primary surgical resection and patients treated with neoadjuvant systemic therapy. Panelists will discuss the optimal approaches to axillary staging, how to avoid overtreatment of the axilla, associated comorbidities, and optimized accuracy of less invasive options.
AJCC staging systems
The AJCC [American Joint Committee on Cancer] Cancer Staging Manual, Eighth Edition, was released in October 2016, and the guidelines in it will be implemented in January 2018. The changes in the new edition are more significant than in the past, with the incorporation of tumor biology and additions to classic tumor/node/metastasis classifications. If you are not up to speed with the new staging system or have questions, plan to attend Evolving Concepts in the AJCC Staging Systems: Breast Cancer, Colorectal, and Melanoma, 2:30–4:00 pm, Tuesday, October 24, moderated by David J. Winchester, MD, FACS, general surgeon, NorthShore Medical Group, Evanston, IL, and David Byrd, MD, FACS, professor of surgery and section chief of surgical oncology, University of Washington, Seattle. This session, co-sponsored by the CoC, will provide an overview of the changes in the AJCC Cancer Staging Manual, Eighth Edition, as well as clinical staging examples. The session will be important to ensure that surgeons are aware of the changes and provide an opportunity for questions so that surgeons are ready for implementation in January.
ACS Operative Standards for Cancer Surgery
In 2015, the ACS CRP published Operative Standards for Cancer Surgery Volume I, which reviews evidence-based optimal operative techniques for breast, colon, lung, and pancreatic cancer. Volume II is about to be released and covers operations for melanoma and esophageal, gastric, rectal, and thyroid cancers. Chaired by Matthew Katz, MD, FACS, associate professor, department of surgical oncology, division of surgery, the University of Texas MD Anderson Cancer Center, Houston, and Waddah Al-Refaie, MD, FACS, chief, surgical oncology, MedStar Georgetown University Hospital, Washington, DC, ACS Operative Standards for Cancer Surgery, 4:15–5:15 pm, Tuesday, October 24, will review evidence-based optimal techniques for cancer surgery. The manuals provide a comprehensive, evidence-based examination of cancer surgery techniques as standards and identify the well-defined protocols and techniques that are critical to achieve optimal outcomes in oncologic surgery. Volume I and Volume II will be available for purchase and pre-purchase, respectively, at the Wolters Kluwer booth.
Emerging technologies panel discussion
If you are interested in new techniques in the surgical management of liver and pancreas cancer and want to learn how to incorporate some of these emerging technologies safely into your clinical practice, consider attending Controversies and the Appropriate Incorporation of Emerging Technologies in Multidisciplinary Treatment of Liver and Pancreatic Cancer. The Panel Session will take place 8:00–9:30 am, Wednesday, October 25, and is co-sponsored by the Committee on Emerging Surgical Education and Technology. Moderated by Clancy Clark, MD, FACS, general surgeon, Wake Forest Baptist Health, Winston-Salem, NC, and Georgios Tsoulfas, MD, FACS, President, ACS Greece Chapter, the session will review the efficacy of minimally invasive surgery, irreversible electroporation, and stereotactic body radiation therapy, and how to introduce them into practice.
Understanding clinical trial results
Many advances in patient care stem from clinical trial results. Understanding these trials and their findings and identifying how they can and should be incorporated into your clinical practice can be challenging. Learn more during Clinical Trial Results: Why and How You Should Incorporate Them into Your Practice, 4:15–5:45 pm, Wednesday, October 25. Moderator Kelly K. Hunt, MD, FACS, Director of the ACS CRP and co-author of this column, will review results from recent clinical trials in cancer.
ACS CRP networking session
If you are interested in getting more involved in the ACS CRP or learning more about the program, consider attending the Networking Session, 6:00–7:00 pm, Sunday, October 22, at the Manchester Grand Hyatt Hotel, America’s Cup A, Fourth Level. Hors d’oeuvres, beer, and wine will be served. Contact Amanda Francescatti, Senior Manager, ACS CRP, at email@example.com to RSVP or to learn about opportunities to participate in the ACS CRP.
Table 1. Summary of ACS CRP Clinical Congress Sessions
|Sunday, October 22, 6:00–7:00 pm||Clinical Research Program Networking Session|
|Monday, October 23, 11:30 am–1:00 pm||Management of the Axilla in Breast Cancer|
|Tuesday, October 24, 2:30–4:00 pm||Evolving Concepts in the AJCC Staging Systems: Breast Cancer, Colorectal and Melanoma|
|Tuesday, October 24, 4:15–5:15 pm||ACS Operative Standards for Cancer Surgery, Volume I|
|Wednesday, October 25, 8:00–9:30 am||Controversies and the Appropriate Incorporation of Emerging Technologies in Multidisciplinary Treatment of Liver and Pancreatic Cancer|
|Wednesday, October 25, 4:15–5:45 pm||Clinical Trial Results: Why and How You Should Incorporate Them into Your Practice|